(PFO) |
| 0 (0%) 10-10 07:12 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 11.56 |
| Resistance 1: | 9.90 |
| Pivot price: | 9.77 |
| Support 1: | 9.57 |
| Support 2: | 9.37 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | 0.920 |
| Book Value | 9.900 |
| PEG Ratio | 0.00 |
| Gross Profit | 1.102 |
| Profit Margin (%) | 83.54 |
| Operating Margin (%) | 87.26 |
| Return on Assets (ttm) | 3.8 |
| Return on Equity (ttm) | 9.4 |
Company news
Thu, 09 Oct 2025
Her stroke revealed a heart defect — weeks before her semester in London. Could she still go? - www.heart.org
Fri, 03 Oct 2025
Morphotype-based risk stratification in patients with patent foramen ovale using computational fluid dynamics - Nature
Thu, 18 Sep 2025
Patent Foramen Ovale Shunting Induced by Tricuspid Regurgitation: Unusual Cause of Dyspnea After Heart Transplantation - ScienceDirect.com
Mon, 23 Jun 2025
15-Year Outcomes of PFO Closure in Patients With Cryptogenic Embolism: Insights From the PROLONG Registry - JACC Journals
Tue, 03 Jun 2025
Patent foramen ovale in patients with cryptogenic stroke: to close or not to close? - European Society of Cardiology
Tue, 27 May 2025
PFO Device Closure in Patients >60 Years of Age With Ischemic Stroke: Results From U.S. Medicare Beneficiaries - JACC Journals
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
